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A human hepatocellular carcinoma-derived c llline, PLC/PRF/5, was examined for its ability to respond to epidermal 
growth factor (EGF) exposure with increased phosphatidylinositol 4,5-bisphosphate hydrolysis. Upon addition of EGF 
(25 ng/ml), a rapid (10-15 s) but transient increase in Ins(1,4,5)P 3 levels and large, prolonged (2 min) increases in 
Ins( 1,3,4,5)P 4 and Ins(1,3,4)P 3 levels were detected. Increases incytosolic Ca 2 + were observed after a ! 0 to 20 s lag, reach- 
ing peak value at 1 min, and remaining elevated for 10 min. The initial burst of cytosolic Ca 2+ occurred in the absence 
of extracellular Ca 2 + and probably reflects mobilization of intracellular Ca 2 + stores. In cells pretreated with EGTA, the 
sustained component of the Ca 2 + response was not observed. Comparison of the inositol phosphate and Ca z + responses 
of PLC/PRF/5 cells to responses reported in other cell types indicates that this cell line is a good model for EGF action 
in liver. 
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1. INTRODUCTION 
Epidermal growth factor (EGF) acts as a 
mitogen for several cell types; however, the rela- 
tionship between EGF receptor-ligand binding and 
induction of cell proliferation remains undefined 
[1,2]. The EGF receptor possesses an intrinsic 
tyrosine-specific protein kinase which is stimulated 
upon ligand binding and results in receptor 
autophosphorylation and phosphorylation of 
several specific cellular substrates [3-6]. Muta- 
tions that abolish the receptor kinase activity block 
EGF induction of DNA synthesis in NIH 3T3 cells 
[7]. 
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Recent studies link EGF receptor activation to 
enhanced breakdown of phosphatidylinositols, a 
signalling pathway activated by a number of 
growth-promoting stimuli [8-14], Diacylglycerol 
and inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) are 
formed upon hydrolysis of phosphatidylinositol 
4,5-bisphosphate (PIP2) by phospholipase C and 
have been implicated in cellular egulation by their 
respective abilities to activate protein kinase C and 
mobilize intracellular stores of Ca 2÷ [15-18]. The 
metabolite of Ins(1,4,5)P3, inositol 1,3,4,5-tetra- 
kisphosphate (Ins(1,3,4,5)P4), may also influence 
cytosolic Ca 2+ levels [181. 
The tyrosine-protein kinase and phospholipid 
signalling pathways may interconnect. Phospha- 
tidylinositol (PI) kinase co-purifies with the EGF 
receptor [19] and the platelet-derived growth 
factor receptor, another tyrosine-specific protein 
kinase, has been shown to phosphorylate a puta- 
tive PI kinase [20]. EGF appears to directly 
stimulate PI kinase activity in A431 cells [13] and 
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to stimulate phospholipase C activity in A431 cells 
and rat hepatocytes [10-14]. However, this con- 
nection is still controversial nd may depend upon 
cell type or the metabolic onditions. In one study, 
for instance, the EGF-induced rises in cytoplasmic 
Ca 2+ observed in A431 cells were solely at- 
tributable to Ca 2+ influx [21]. EGF also did not 
cause measurable increases in membrane 
polyphosphoinositides in rat liver preparations 
[22] or in inositol phosphates of BALB/C 3T3 cells 
[23]. 
In this report we described EGF-induced 
cytosolic Ca 2+ fluxes and Ins(1,4,5)P3 production 
in a differentiated human cell line, PCL/PRF/5.  
This hepatoma-derived cell line, which contains 
approximately 300000 EGF receptor molecules per 
cell, exhibits some of the properties of differen- 
tiated hepatocytes [24-26] and may provide a good 
model system for study of coupling between EGF 
receptor activation and PIP2 hydrolysis. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
PLC/PRF /5  cells were cultured in Eagle's minimum essential 
medium (MEM) supplemented with 10% heat-inactivated fetal 
bovine serum and 2 mM glutamine. Cells were maintained and 
labelled in a humidified CO2 incubator at 37°C. 
2.2. Inositol phosphate labelling 
PLC/PRF /5  cells were seeded at l - l .5  × l0  6 cells per 
100 mm dish. After 5 days, the medium was replaced with 
10 ml of medium containing 3/~Ci of myo-[2-3H]inositol 
(Amersham, 20 Ci/mmol) per ml. After 24 h, this medium was 
exchanged for serum-free MEM containing 3 ,uCi of myo- 
[2-3H]inositol per ml and incubated for another 18-22 h. Cells 
were washed twice with Dulbecco's phosphate buffered saline 
(PBS, Gibco), preincubated with serum-free MEM containing 
0.1% bovine serum albumin (BSA) for 45 min at 37°C, and 
washed 3 times with PBS. Cells were then incubated with 
25 ng/ml EGF (Collaborative Research, receptor grade) for 0, 
10 to 15 s, or 2 min at 37°C and scraped after addition of 
0.8 ml of ice-cold 10% trichloroacetic acid (TCA). The plates 
were washed once with 0.8 ml of 10% TCA and insoluble 
material removed by centrifugation. The TCA extracts were 
washed 4 times with water-saturated diethylether, lyophilized, 
stored at -70°C ,  and reconstituted with water prior to 
separation by high-pressure liquid chromatography (HPLC). 
2.3. HPLC analysis 
lnositol phosphates were separated on a Whatman Partisil 
Sax l0 column using a variation of the procedure of Irvine [27]. 
The following ammonium formate (pH 3.7 with phosphoric 
acid) elution sequence was used at a flow rate of 1.2 ml/min: 
0.625 M for 9 min; 1.425 M from 10 to 18 min; 2.5 M from 20 
200 
150 
100 
50 
0 
10 
A. 
IP5 
IP3 
IP4 
1,4,5-1P3 ~ 
I I I I I I 
20 30 40 50 60 70 
200 
150 
100 
50 
B. 
I i ] 
20 30 70 
I I I 
40 50 60 
200 
CPM 
C,  
150 
1 O0 
50 
0 
0 
I ! 
20 30 
1,3,4-1P3 
i2. 
4 50 
Fraction Number 
I I 
60 70 
Fig.l. Separation of highly phosphorylated inositol phosphate 
isomers from EGF-treated cells by anion exchange HPLC.  
PLC/PRF /5  cells previously labelled with tritiated myo-inositol 
were treated with 25 ng/ml EGF for 0 (A), 10-15 s (B), and 
2 rain (C) and acid extracts of the cells injected into a Partisil 
Sax 10 HPLC column. 0.6 ml fractions were collected and 
tritium counts in each fraction measured. 
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to 35 min. Fractions (0.6 ml) were collected every 0.5 min. 
Fractions 1-39 were directly diluted with 0.9 ml of 50070 
methanol and mixed with 4.5 ml of ACS II scintillation fluid 
(Amersham). To avoid quenching of radioactivity due to high 
salt, 0.3 ml of each fraction beyond fraction 39 was replaced 
with 0.3 ml of water prior to the addition of  0.9 ml of 50070 
methanol. Samples were counted on the tritium channel of a 
Beckman scintillation counter. 
2.4. Ca z+ measurements  
The medium in a T-75 flask of PLC/PRF /5  cells was 
exchanged for serum-free MEM 1-2 days prior to confluence. 
16 h later, cells were detached by incubation with 0.25070 trypsin 
and 0.1070 EDTA in PBS for 1-2 min at 37°C, diluted 
immediately with serum-free medium containing 0.25070 BSA 
and 10 mM NaHepes (pH 7.4) (incubation medium), and 
centrifuged. Cells detached using EDTA alone gave similar 
results. After washing once, the cells were resuspended in 5 ml 
of the incubation medium and incubated at 37°C with 2/zM 
Fura 2 /AM (Calbiochem-Behring) for 30 min. Cells were 
diluted, centrifuged, washed once, resuspended in 5 ml of 
incubation medium and incubated at 37°C for 15 min to 
complete intracellular conversion of Fura 2 /AM to Fura 2. 
Cells were pelleted, resuspended in 200-400/zl of incubation 
medium and Ca 2+ measurements made as previously described 
[28]. Briefly, the fluorescence of Fura 2-loaded cells was 
monitored using an MB-2 four filter air turbine fluorescence 
spectrometer (Johnson Foundation, University of 
Pennsylvania) at the excitation wavelengths of 340 nm 
(Ca2+-Fura 2 complex) and 385 nm (free Fura 2) and at the 
emission wavelength of 510 nm. Because the fluorescence 
recordings at 385 nm had a better signal-to-noise ratio, results 
are presented using the free Fura 2 signal. 
3. RESULTS 
The ability of EGF to induce formation of 
Ins(1,4,5)P3 in PLC/PRF/5 cells was investigated 
using HPLC chromatography to separate highly 
phosphorylated isomers of inositol. The 
chromatograms of acid-soluble extracts from cells 
treated with 25 ng/ml EGF for 0, 10-15 s, and 
2 min are shown in fig. 1. The data are uncorrected 
except for a dilution correction for the fractions 40 
and above. Ins(l,4,5)P3 and Ins(1,3,4,5)P4 peaks 
were identified by coinjection of known standards 
(New England Nuclear) and were present at signifi- 
cant levels in unstimulated cells. Substantial levels 
of 2 unidentified peaks were also observed. The 
first of these peaks migrated in the region where 
inositol trisphosphate lute, while the second 
eluted in high salt, after Ins(l,3,4,5)P4. These 
peaks were tentatively identified as an inositol 
trisphosphate isomer (InsP3) and inositol pen- 
takisphosphate (InsPs). 10-15 s after EGF addi- 
tion, the same four peaks were prominent; 
however, the Ins(1,4,5)P3 and Ins(1,3,4,5)P4 peaks 
appeared larger. At 2 min after addition of EGF, 
Ins(1,4,5)Pa had decreased, Ins(1,3,4,5)P4 remain- 
ed elevated, and an inositol 1,3,4-trisphosphate 
(Ins(1,3,4)P3) peak, identified by its chroma- 
tographic behavior and its characteristic delayed 
appearance upon stimulation [29-32], had become 
apparent. 
Table 1 summarizes the results from three 
separate experiments. The inositol phosphate 
levels vary widely between experiments; however, 
all experiments show the same pattern of inositol 
phosphate metabolism. A consistent, though tran- 
sient increase in Ins(1,4,5)P3 was observed after 
EGF addition. Levels were between 2 and 3 times 
above basal 10-15 s after EGF addition but had 
returned to prestimulatory values after 2 min. 
Table 1 
Levels of highly phosphorylated inositol phosphate isomers in PLC/PRF/5  cells stimulated with 
epidermal growth factor 
Expt 1 Expt 2 Expt 3 
0 10-15 s 2 min 0 10-15 s 2 min 0 10-15 s 2 min 
InsP3 101 109 100 215 176 205 264 264 259 
lns(l,3,4)P3 0 0 51 a 0 0 128 a 0 0 79 a 
lns(1,4,5)P3 33 71 a 32 36 102 a 38 19 48 a 19 
lnsP4 52 58 67 a 35 85 ~ 148 a 14 24 a 70 a 
lnsPs 533 549 486 654 599 567 275 335 344 
a Levels that differ from the 0 control (no EGF) by more than 25°70 
Cells were exposed to 25 ng/ml  EGF for 0, 10 to 15 s, and 2 min. Values were corrected for 
background and dilution (fractions 40 and above) and expressed as cpm per mg of cell protein 
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Ins(1,3,4,5)P4 increases were observed in some ex- 
periments 10-15s after EGF addition, but 
substantial increases were always present after 
2 min of stimulation. The production of 
Ins(1,3,4)P3 was delayed, but this isomer was pre- 
sent at high levels 2 min after EGF addition. 
The unassigned InsP3 and InsP5 peaks did not 
change by more than 25 % upon EGF addition and 
their function is unknown. The very high levels of 
the unassigned InsP3 and InsP5 present in 
PLC/PRF/5 cells and the high levels of InsP5 and 
InsP6 present in other cell types upon long term 
labelling [32,33] make separation of the inositol 
phosphates into individual isomers essential. Pro- 
tocols that do not enable separation of all isomers 
can lead to several underestimation of ligand- 
induced inositol phosphate increases [33]. In ex- 
periment no.2 of table 1, for example, the number 
of counts in the Ins(1,4,5)P3 increased almost 
3-fold, from 36 to 102, when cells were exposed to 
PLC/PRF/5 
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Fig.2. EGF-induced increases in cytosolic Ca z+ in the presence 
(A) and absence (B) of extracellular Ca 2+. Changes in 
fluorescence (arbitrary units) are plotted versus time after EGF 
(25 ng/ml) addition to PLC/PRF /5  cells. Fluorescence 
measurements shown are at excitation wavelength 385 nm and 
emission wavelength 510 nm. An increase in fluorescence 
indicates an increase in cytosolic Ca z+. The instantaneous 
decrease in fluorescence observed upon EGTA addition occurs 
because of removal of Ca 2+ from extracellular Ca2+-Fura 2 
complexes. 
EGF for 10-15 s. At the same time, the counts in 
the three InsP3 peaks combined increased by only 
11%, going from 251 to 278. 
The physiological consequences of enhanced 
inositol phosphate production were assessed by 
measuring the EGF-induced changes in cytosolic 
Ca 2÷ in the absence and presence of 5 mM EGTA 
(fig.2). After a 10-20 s lag, EGF addition caused 
the cytosolic Ca 2÷ to increase from 114 nM to 
306 nM (n = 6) within approximately 1min 
(fig.2A). After an initial decrease from peak 
values, the cytosolic Ca 2÷ remained elevated for at 
least 10 min. Removal of extracellular Ca 2÷ by 
prior addition of EGTA only lowered peak Ca 2÷ 
values by 26% (n = 4); however, cytosolic Ca 2÷ 
returned to basal levels within 3 min (fig.2B). 
4. DISCUSSION 
The EGF-induced alterations in inositol 
phosphate l vels in PLC/PRF/5 ceils are similar to 
those observed in A431 cells exposed to EGF 
[10,14]. These patterns are consistent with initial 
stimulation of Ins(1,4,5)P3 formation, phospho- 
rylation of that isomer to form Ins(1,3,4,5)P4, and 
formation of Ins(l,3,4)P3 by an inositol 5'-phos- 
phatase [29-32]. The transient nature of the 
Ins(1,4,5)P3 increase may reflect Ca 2÷ stimulation 
of the kinase which converts it to Ins(1,3,4,5)P4 
[34,35] and protein kinase C activation of the 
5'-phosphatase which converts it to inositol 1,4- 
bisphosphate [36]. Ins(1,3,4)P3 production may be 
enhanced by EGF through stimulation of a similar 
5' -phosphatase activity, as well as by the increased 
production of its precursor, Ins(1,3,4,5)P4. The 
production of diacylglycerol which should result in 
protein kinase C activation is inferred from the 
high production of Ins(1,4,5)P3 metabolites, in- 
dicating continual hydrolysis of PIP2. Production 
of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 directly from 
InsP5 has not been previously reported and is 
unlikely to have occurred here, since InsP5 levels 
did not change by more than 25% within 2 min of 
EGF addition. 
The change in Ca 2÷ levels in the EGF-treated 
cells indicates that the changes in inositol 
phosphates are physiologically significant. The in- 
itial rise in cytosolic Ca 2÷ occurs after the peak in 
Ins(1,4,5)P3 and is probably due to mobilization of 
endoplasmic reticulum Ca 2÷ stores by this InsP3 
44 
Volume 233, number l FEBS LETTERS June 1988 
isomer. The later component of the Ca 2+ response 
depends upon the presence of extracellular Ca 2+ 
and may be contributed by influx across 
Ins(1,3,4,5)P4-activated plasma membrane Ca 2+ 
channels [30,37,38]. The dual component of the 
Ca 2+ response to EGF in this cell line is similar to 
that observed in the A431 cell line and in primary 
rat hepatocytes [10-12] and may be a uniform 
response to EGF in cells where EGF receptor 
coupling to PI hydrolysis is intact. 
Our results and those obtained recently in 
primary rat hepatocytes [11] argue against a re- 
quirement for very high levels of EGF receptor in 
the EGF-stimulated production of inositol 
phosphates. The response of PLC/PRF/5  cells to 
EGF was similar to the primary rat cell response; 
however, the primary rat hepatocytes showed sus- 
tained increases in Ins(1,4,5)P3 production [l l] 
whereas our cells did not. This difference may 
reflect the use, in that study, of EGF at doses 
15-fold higher than those in our study and also the 
preincubation of the primary rat hepatocytes with 
Li +. However, both studies clearly establish that 
EGF induces PIP2 hydrolysis in liver-derived cells, 
in contrast to an earlier study in which primary rat 
hepatocytes were found to be unresponsive [22]. 
While different methodologies were used, this 
discrepancy indicates that the ability of primary rat 
hepatocytes to respond to EGF may vary with 
hepatocyte preparation. EGF receptor levels in rat 
hepatocytes, for example, vary depending upon 
the nutritional state of the animal from which they 
are isolated [39]. Thus, the PLC/PRF/5  cell line 
may be a good model system for examining EGF 
receptor action in liver since EGF receptor activa- 
tion is still coupled to the inositol phosphate 
signalling pathway and culture conditions can be 
rigidly controlled. 
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